A March 4, 2026 FDA update says families should use standard choking first aid first, not reach for a suction device. Here’s how to recognize severe choking and what to do for adults, children, and infants.
Medicare covers some diabetes-related foot care in 2026, but not unlimited routine foot care for everyone. Here’s who qualifies for Part B foot exams and treatment every 6 months, what therapeutic shoes may be covered, what you may pay, and which symptoms should be checked sooner.
New CDC data show black-lung-associated deaths rose from 2020 to 2023, and NIOSH has announced free 2026 screenings for coal miners. Here’s what the numbers mean, what they do not prove, and what miners and families can do now.
CDC reported 1,575 confirmed U.S. measles cases and 16 outbreaks as of March 26, 2026. Here’s what outbreak preparedness looks like now, and what families can do.
As of March 27, 2026, the CDC still clearly recommends 2 doses of the 2025–2026 COVID-19 vaccine for adults 65 and older. Here is how the timing works, why age still matters, what Medicare covers, and what remains uncertain.
FDA has stepped up action against compounded GLP-1 weight-loss drugs sold online and through telehealth. Here’s what changed in 2026, why the agency says shortages no longer justify broad copycat compounding, what safety problems it has flagged, and how to protect yourself before buying.
FDA says Silintan capsules sold online nationwide contained undeclared meloxicam, an NSAID that can raise the risk of bleeding, ulcers, kidney injury, heart attack, and stroke in some users.
The FDA has classified a recall for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors as Class I, its most serious recall type. The issue is falsely low glucose readings from some sensor lots. Here is what is affected, what is not, how to check your sensor, and what to do if a reading does not match how you feel.
A February 2026 recombinant mpox report has not changed the basic advice for most people in the United States: you cannot tell the strain by looking at a rash, and a new unexplained sore or skin lesion still needs medical evaluation.
New Alzheimer’s blood tests are becoming part of clinical care in the United States, but they are not simple screening tools for anyone worried about forgetfulness. Here’s what the FDA cleared, what specialists recommend, and what families should ask before treating a blood result as proof of Alzheimer’s disease.
Stryker’s March 2026 cyberattack is a reminder that patients can feel the effects of a vendor disruption through shipping delays, manual workarounds, and some rescheduled procedures, even when their hospital was not directly hacked.
The FDA has approved Nuzolvence, an oral form of zoliflodacin, for some uncomplicated gonorrhea cases. Here is what the phase 3 trial found, what noninferior means, and why this does not apply to every gonorrhea infection.
A 2026 Medicare policy update gives eligible beneficiaries more ways to join the Medicare Diabetes Prevention Program, including live online and on-demand sessions through December 31, 2029. Here’s who qualifies, what the program includes, what Medicare pays, and why the access change matters for older adults with prediabetes.
Henderson, NV – March 25, 2026 – Boulder City Hospital plans to convert to a Rural Emergency Hospital on May 1, ending inpatient admissions and shifting to 24/7 emergency and ou…
New Orleans, LA – March 25, 2026 – Louisiana Medicaid members enrolled in UnitedHealthcare must select a new plan before April 1 to avoid coverage disruption.
A new NCCIH consumer update and a large recent JAMA trial point in the same direction: spinal manipulation may help some people with low back pain, but average benefits are usually small, and it works best as one part of a broader plan built around movement, exercise, and self-management.
A new federal update says self-collected HPV testing should be offered as an option for average-risk women ages 30 to 65. Here’s what changed, what did not, and why many insurance plans may not have to cover the new option with no out-of-pocket costs until plan years that start in 2027.
A new Nature Medicine study suggests a blood-based model may help estimate when Alzheimer’s symptoms could begin, but the research is not a consumer screening test. Here’s what the study actually found, what U.S. patients can access now, and why memory symptoms still need a full medical workup.
The FDA’s December 19, 2025 decision could make some osteoporosis drug trials smaller and faster. But it does not change who should get screened, how osteoporosis is diagnosed, or what most patients should do today.
Roche’s FDA-cleared pTau181 blood test brings Alzheimer’s biomarker testing closer to everyday care, but right now it is mainly for adults 55 and older who already have cognitive symptoms, and a positive result still usually needs more workup. ([accessdata.fda.gov](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K252163))
Long Beach, CA – March 25, 2026 – City budget pressures, VA hospital upgrades and ongoing measles cases in L.A. County shape this week’s local health outlook.
Sacramento, CA – March 25, 2026 – Measles cases in nearby Placer County and new Covered California enrollment figures bring fresh health updates for Sacramento-area residents.
End of content
End of content
